Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Camp4 Therapeutics Corp | 170,010 | reported | 11 Sept 2025 | tx 4+33,068−100,014 |
| Omega Therapeutics, Inc. | 25,000 | reported | 20 Jun 2024 | tx 9+61,236−55,000 |
| Viskase Holdings, Inc. | 20,129 | reported | 02 Jan 2013 | tx 9+80,350−19,673 |
| Syros Pharmaceuticals, Inc. | 10,667 | reported | 16 Sept 2024 | tx 38+163,833−257,781 |
| TELECOMMUNICATION SYSTEMS INC /FA/ | 0 | reported | 23 Feb 2016 | tx 85+2,990,382−3,237,444 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Sept 2025 | PURCHASE | Camp4 Therapeutics Corp | 15,151 | 1.65 USD | first after silence |
| 25 Jun 2025 | GRANT_AWARD | Camp4 Therapeutics Corp | 9,000 | 0.00 USD | deriv |
| 15 Oct 2024 | CONVERSION | Camp4 Therapeutics Corp | 8,917 | — | |
| 15 Oct 2024 | CONVERSION | Camp4 Therapeutics Corp | 100,014 | — | deriv |
| 16 Sept 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,667 | — | |
| 16 Sept 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,667 | 0.00 USD | deriv |
| 28 Jun 2024 | SALE | Syros Pharmaceuticals, Inc. | 34,837 | 5.12 USD | |
| 20 Jun 2024 | GRANT_AWARD | Omega Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 16 Sept 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,666 | — | |
| 16 Sept 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,666 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Omega Therapeutics, Inc. | 18,118 | 0.00 USD | deriv |
| 02 Jun 2023 | SALE | Omega Therapeutics, Inc. | 5,000 | 8.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 01 May 2023 | SALE | Omega Therapeutics, Inc. | 5,000 | 8.00 USD | |
| 06 Apr 2023 | SALE | Omega Therapeutics, Inc. | 5,000 | 8.00 USD | |
| 17 Mar 2023 | SALE | Omega Therapeutics, Inc. | 10,000 | 8.00 USD | |
| 10 Jan 2023 | SALE | Omega Therapeutics, Inc. | 20,000 | 8.00 USD | |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 8,000 | 0.00 USD | deriv |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 14 Sept 2022 | SALE | Omega Therapeutics, Inc. | 10,000 | 8.00 USD | |
| 08 Jun 2022 | GRANT_AWARD | Omega Therapeutics, Inc. | 18,118 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 11 Sept 2025.